KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zoetis (ZTS) Other Operating Expenses: 2012-2021

Historic Other Operating Expenses for Zoetis (ZTS) over the last 9 years, with Mar 2021 value amounting to -$405.0 million.

  • Zoetis' Other Operating Expenses fell 424.00% to -$405.0 million in Q1 2021 from the same period last year, while for Mar 2021 it was -$1.0 billion, marking a year-over-year decrease of 165.46%. This contributed to the annual value of -$927.0 million for FY2019, which is 8.80% down from last year.
  • Per Zoetis' latest filing, its Other Operating Expenses stood at -$405.0 million for Q1 2021, which was down 5.47% from -$384.0 million recorded in Q3 2020.
  • In the past 5 years, Zoetis' Other Operating Expenses ranged from a high of $1.2 billion in Q4 2019 and a low of -$405.0 million during Q1 2021.
  • For the 3-year period, Zoetis' Other Operating Expenses averaged around $68.2 million, with its median value being $124.5 million (2019).
  • Its Other Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 108.97% in 2018, then tumbled by 424.00% in 2021.
  • Zoetis' Other Operating Expenses (Quarterly) stood at $535.0 million in 2017, then soared by 108.97% to $1.1 billion in 2018, then grew by 7.42% to $1.2 billion in 2019, then tumbled by 400.00% to -$384.0 million in 2020, then slumped by 424.00% to -$405.0 million in 2021.
  • Its Other Operating Expenses stands at -$405.0 million for Q1 2021, versus -$384.0 million for Q3 2020 and -$369.0 million for Q2 2020.